Filing excerpt
In June 2026, MINJUVI was approved by Japan’s Ministry of Health, Labour and Welfare (“MHLW”) for the treatment of adults with r/r DLBCL in combination with lenalidomide.
Source: Autobound Signal API · 75 signals tracked for Incyte · updated
Get Incyte's live signals in Claude or ChatGPT, or by API
What changed at Incyte this week? Use Autobound signals for incyte.com.Japan's Ministry of Health, Labour and Welfare approved MINJUVI in combination with lenalidomide for adult patients with r/r DLBCL in June 2026. This geographic expansion into Japan may require international regulatory, logistics, and local commercial support services.
Filing excerpt
In June 2026, MINJUVI was approved by Japan’s Ministry of Health, Labour and Welfare (“MHLW”) for the treatment of adults with r/r DLBCL in combination with lenalidomide.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qmarketExpansionGet every 10-Q signal for Incyte and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Incyte this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/9876e219-547c-4b10-959b-f6cf888c227b returns this record as JSON. POST /v1/companies/enrich returns every signal for incyte.com.
{
"signal_id": "9876e219-547c-4b10-959b-f6cf888c227b",
"signal_type": "sec-10q",
"signal_subtype": "marketExpansion",
"detected_at": "2026-11-09T06:30:46.095+00:00",
"company": {
"name": "Incyte",
"domain": "incyte.com"
},
"data": {
"detail": "Japan's Ministry of Health, Labour and Welfare approved MINJUVI in combination with lenalidomide for adult patients with r/r DLBCL in June 2026. This geographic expansion into Japan may require international regulatory, logistics, and local commercial support services.",
"metrics": {
"timeframe": "current_quarter"
},
"quarter": "Q2",
"summary": "MINJUVI Secures Approval from Japan MHLW in June 2026 for Relapsed/Refractory DLBCL",
"excerpts": "In June 2026, MINJUVI was approved by Japan’s Ministry of Health, Labour and Welfare (“MHLW”) for the treatment of adults with r/r DLBCL in combination with lenalidomide.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000056/incy-20260630.htm",
"filing_date": "2026-07-28",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "06/30",
"period_end_date": "2026-06-30",
"sales_relevance": "Scaling infrastructure needed",
"signal_category": "market",
"regions_mentioned": [
"Japan"
]
}
}
curl https://signals.autobound.ai/v1/signals/9876e219-547c-4b10-959b-f6cf888c227b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"incyte.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.